Metrics as of 10/17/2026, 05:48 AM (Berlin time), refresh in progress.
HeartSciences Stock
HeartSciences Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Andrew Simpson
- Employees
- 14
- Market cap
- $15 M
- IPO
- 16/06/2022
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other…
HeartSciences stock: price history
1D
-5.0%
1W
-5.0%
1M
-20.3%
6M
+40.5%
YTD
-2.3%
1Y
-11.4%
2Y
-15.4%
5Y
–
10Y
–
Next earnings date
Next earnings date
21/12/2026 (in 65 days)
Volatility around earnings
~16% stronger price swings than usual
Ask the agents about HeartSciences
Analyst assessment of HeartSciences
PRICE TARGET LOW
US$3.00
CONSENSUS
US$3.00
MEDIAN
US$3.00
PRICE TARGET HIGH
US$3.00
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 24/03/2026
HeartSciences stock metrics
P/E
-0.94
P/B
-5.45
EV/EBITDA
1.21
RETURN ON EQUITY
156.0%
NET MARGIN
-151,064.0%
DEBT/EQUITY
-1.97
DIVIDEND YIELD
0.0%
AS OF
31/07/2026
Free float & liquidity
FREE FLOAT
79.6%
FLOAT SHARES
3,854,193
AVG. DAILY VOLUME (30D)
226,218
Dividends & Stock splits
Comparable stocks
Frequently asked questions about HeartSciences stock
What does HeartSciences do?
HeartSciences Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Andrew Simpson, the company employs around 14 people.
The IPO was on 16/06/2022; the stock trades on NASDAQ under the ticker HSCS.
What do analysts say about HeartSciences stock?
3 analysts rate the stock, the consensus is Buy (as of 24/03/2026).
The average price target is US$3.00, ranging from US$3.00 to US$3.00, with a median of US$3.00.
This is an external assessment, not a statement by Market Jury.
When does HeartSciences report next?
The next earnings date is 21/12/2026.
Around past earnings, price swings were roughly 16% stronger than usual.
Does HeartSciences pay a dividend?
No, HeartSciences currently does not pay a dividend.
Which stocks are comparable to HeartSciences?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get HeartSciences stock analyzed?
Clicking "Analyze stock" lets five strategies assess HeartSciences against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.